Cigna Corporation (CI)

I believe the odds favor long-term market gains. Analysts' optimism supports my view that overlooked areas offer the best opportunities now. That's why I'm focusing on two dividend stocks with rising ...

CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors.

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #kerecis--Cigna Insurance Company now includes Kerecis products in its medical coverage policy for the treatment of diabetic foot ulcers.

Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more than $200 a month out-of-pocket for weight-loss drugs Wegovy and Zepbound.

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs ...

The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...

The abrupt departure of UnitedHealth (NYSE:UNH) CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector.

Live Updates Live Coverage Has Ended Goldman's Warning 2:30 pm by Gerelyn Terzo Wall Street firm Goldman Sachs believes there’s still another shoe yet to drop in the trade wars despite prog...